CMIC HOLDINGS Co.,Ltd. (E05292) Cash flow
Market cap
P/E ratio
Symic Holdings supports pharmaceutical companies through the entire drug lifecycle with research, development, manufacturing, and sales services, while also providing digital healthcare solutions to medical facilities and communities.
| 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | |
| Depreciation & amortization | 1,833 | 1,579 | 2,314 | 2,566 | 2,822 | 3,127 | 3,620 | 4,529 | 5,161 | 5,227 | 4,660 |
| Cash from operations | 5,201 | 2,677 | 889 | 6,493 | 4,937 | 7,488 | 4,922 | 6,703 | 9,804 | 11,213 | 10,449 |
| Capital expenditures | -3,283 | -2,158 | -3,108 | -4,140 | -6,343 | -5,609 | -3,935 | -7,915 | -6,527 | -6,508 | -5,417 |
| Cash from investing | -4,059 | -6,910 | -3,461 | -4,639 | -7,541 | -6,203 | -4,889 | -8,542 | -6,685 | -8,045 | 2,136 |
| Payments for dividends | -672 | -636 | -648 | -190 | -301 | -519 | -514 | -581 | -456 | -610 | -883 |
| Repurchases of common stock | -213 | - | -458 | - | - | -326 | -1,000 | - | - | -800 | -1,260 |
| Proceeds from issuance of term debt, net | 2,200 | 5,500 | 3,400 | 3,000 | 6,000 | 4,000 | 2,000 | 2,250 | 5,800 | 4,700 | 3,500 |
| Repayments of term debt | -1,180 | -2,165 | -3,537 | -3,084 | -2,936 | -3,021 | -3,648 | -2,849 | -3,259 | -3,684 | -2,770 |
| Cash from financing | -2,587 | 3,111 | 1,904 | -2,391 | 2,458 | 7,770 | -1,764 | 2,354 | -6,348 | -1,230 | -1,606 |